{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-070353","form_type":"8-K","ticker":"NEOG","cik":"0000711377","company_name":"NEOGEN CORP","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.070515+00:00","generated_at":"2026-05-21T19:17:57.641964+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Neogen announces board retirement of James P. Tobin, appoints Andrea Wainer effective June 1, 2025","bullets":["James P. Tobin retires from Neogen board effective May 31, 2025 after nine years of service.","Andrea Wainer appointed to board effective June 1, 2025; will serve on Governance and Sustainability and Science, Technology, and Innovation Committees.","Wainer brings 25+ years in diagnostics; most recently EVP Rapid and Molecular Diagnostics at Abbott Laboratories.","James C. Borel serves as interim chair of Governance and Sustainability Committee until successor appointed."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-070353","json":"https://secwatch.observer/filing/0000950170-25-070353.json","markdown":"https://secwatch.observer/filing/0000950170-25-070353.md","text":"https://secwatch.observer/filing/0000950170-25-070353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711377/000095017025070353/0000950170-25-070353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711377/000095017025070353/neog-20250513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T19:17:57.641964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ce71d5306","claim":"Andrea Wainer was appointed as Director at NEOGEN CORP.","evidence_excerpt":"Replacing Mr. Tobin, Neogen appoints Andrea Wainer to Neogen’s Board of Directors, effective June 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017025070353/0000950170-25-070353-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ef391b2885","claim":"James P. Tobin retired as Director at NEOGEN CORP.","evidence_excerpt":"announces that James P. Tobin has chosen to retire from the Company’s Board of Directors, effective May 31, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017025070353/0000950170-25-070353-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}